BLUE: bluebird bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 185.67
Enterprise Value ($M) 20.32
Book Value ($M) 222.54
Book Value / Share 1.15
Price / Book 0.83
NCAV ($M) -144.00
NCAV / Share -0.75
Price / NCAV -1.29

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 1.42
Current Ratio 1.55

Balance Sheet (mrq) ($M)
Current Assets 247.08
Assets 613.61
Liabilities 391.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-10 13G/A State Street Corp 1.80 -75.28
02-14 13G Alyeska Investment Group, L.P. 6.32
02-14 13G/A PFM Health Sciences, LP 1.90
02-14 13G Granahan Investment Management Inc/ma 7.38
02-14 13G/A Tang Capital Partners Lp 0.90 -63.33
02-13 13G/A Vanguard Group Inc 4.61 105.69
02-06 13G Goldman Sachs Group Inc 6.40
01-08 13G/A BlackRock Inc. 4.70 21.93

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 3,409,279 6,207,637 54.92
2024-04-17 3,725,783 8,408,712 44.31
2024-04-16 2,377,742 5,915,085 40.20
2024-04-15 2,795,711 821,956 340.13

(click for more detail)

Similar Companies
BDTX – Black Diamond Therapeutics, Inc. BEAM – Beam Therapeutics Inc.
BIIB – Biogen Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc.


Financial data and stock pages provided by
Fintel.io